The World Health Organization has approved Coartem Baby, the first malaria treatment specifically for infants. This is a significant public health milestone, as malaria caused 610,000 deaths in 2024, with three-quarters being children under five in Africa. The new drug offers a safe and effective treatment option where none previously existed for the youngest victims.